Suppr超能文献

鉴定过继输注 NK 细胞在体内的抗肿瘤功能。

Characterizing the anti-tumor function of adoptively transferred NK cells in vivo.

机构信息

Cancer Immunology Program, Cancer Immunotherapy Research Laboratory, Peter MacCallum Cancer Centre, 14 St Andrews Place, East Melbourne, VIC, 3002, Australia.

出版信息

Cancer Immunol Immunother. 2010 Aug;59(8):1235-46. doi: 10.1007/s00262-010-0848-7. Epub 2010 Apr 8.

Abstract

Natural killer (NK) cells represent a promising cell type to utilize for effective adoptive immunotherapy. However, little is known about the important cytolytic molecules and signaling pathways used by NK cells in the adoptive transfer setting. To address this issue, we developed a novel mouse model to investigate the trafficking and mechanism of action of these cells. We demonstrate that methylcholanthrene-induced RKIK sarcoma cells were susceptible to NK cell-mediated lysis in vitro and in vivo following adoptive transfer of NK cells in C57BL/6 RAG-2(-/-)gammac(-/-) mice. Cytotoxic molecules perforin, granzymes B and M as well as the death ligand TRAIL and pro-inflammatory cytokine IFN-gamma were found to be important in the anti-tumor effect mediated by adoptively transferred NK cells. Importantly, we demonstrate that adoptively transferred NK cells could traffic to the tumor site and persisted in vivo which correlated with the anti-tumor effect observed. Overall, the results of this study have important implications for enhancing NK cell-based immunotherapies.

摘要

自然杀伤 (NK) 细胞是一种很有前途的用于有效过继免疫治疗的细胞类型。然而,对于 NK 细胞在过继转移环境中使用的重要细胞溶解分子和信号通路知之甚少。为了解决这个问题,我们开发了一种新的小鼠模型来研究这些细胞的迁移和作用机制。我们证明,甲基胆蒽诱导的 RKIK 肉瘤细胞在过继转移 NK 细胞后,在体外和体内对 NK 细胞介导的裂解敏感。我们发现细胞溶解分子穿孔素、颗粒酶 B 和 M 以及死亡配体 TRAIL 和促炎细胞因子 IFN-γ 在过继转移 NK 细胞介导的抗肿瘤作用中很重要。重要的是,我们证明过继转移的 NK 细胞可以迁移到肿瘤部位并在体内持续存在,这与观察到的抗肿瘤作用相关。总的来说,这项研究的结果对增强基于 NK 细胞的免疫疗法具有重要意义。

相似文献

1
Characterizing the anti-tumor function of adoptively transferred NK cells in vivo.
Cancer Immunol Immunother. 2010 Aug;59(8):1235-46. doi: 10.1007/s00262-010-0848-7. Epub 2010 Apr 8.
3
Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells.
J Immunother Cancer. 2019 Nov 7;7(1):290. doi: 10.1186/s40425-019-0751-5.
4
In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.
J Immunol. 2003 Sep 15;171(6):2953-9. doi: 10.4049/jimmunol.171.6.2953.
5
Distinct requirements for IFNs and STAT1 in NK cell function.
J Immunol. 2000 Oct 1;165(7):3571-7. doi: 10.4049/jimmunol.165.7.3571.
6
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.
J Clin Invest. 2009 May;119(5):1251-63. doi: 10.1172/JCI36022. Epub 2009 Apr 6.
7
Adjuvant effect of anti-4-1BB mAb administration in adoptive T cell therapy of cancer.
Int J Biol Sci. 2007 Nov 20;3(7):455-62. doi: 10.7150/ijbs.3.455.

引用本文的文献

1
Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity.
Int J Mol Sci. 2022 Feb 6;23(3):1833. doi: 10.3390/ijms23031833.
2
Mechanisms of Apoptosis Resistance to NK Cell-Mediated Cytotoxicity in Cancer.
Int J Mol Sci. 2020 May 25;21(10):3726. doi: 10.3390/ijms21103726.
3
T Cells and Regulated Cell Death: Kill or Be Killed.
Int Rev Cell Mol Biol. 2019;342:27-71. doi: 10.1016/bs.ircmb.2018.07.004. Epub 2018 Aug 29.
4
Challenges of NK cell-based immunotherapy in the new era.
Front Med. 2018 Aug;12(4):440-450. doi: 10.1007/s11684-018-0653-9. Epub 2018 Jul 25.
5
Tumor-Associated T-Lymphocytes and Macrophages are Decreased in Endometrioid Endometrial Carcinoma with MELF-Pattern Stromal Changes.
Cancer Microenviron. 2018 Dec;11(2-3):107-114. doi: 10.1007/s12307-018-0213-5. Epub 2018 Jul 14.
6
Granzyme M: behind enemy lines.
Cell Death Differ. 2014 Mar;21(3):359-68. doi: 10.1038/cdd.2013.189. Epub 2014 Jan 10.
7
Granzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis.
Cell Death Differ. 2014 Mar;21(3):416-26. doi: 10.1038/cdd.2013.155. Epub 2013 Nov 1.
9
Toward the next generation of NK cell-based adoptive cancer immunotherapy.
Oncoimmunology. 2013 Apr 1;2(4):e23811. doi: 10.4161/onci.23811.
10
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors.
J Exp Med. 2012 Dec 17;209(13):2351-65. doi: 10.1084/jem.20120944. Epub 2012 Dec 3.

本文引用的文献

1
Oncogenic stress sensed by the immune system: role of natural killer cell receptors.
Nat Rev Immunol. 2009 Aug;9(8):568-80. doi: 10.1038/nri2604.
2
Expansion and activation of natural killer cells for cancer immunotherapy.
Korean J Lab Med. 2009 Apr;29(2):89-96. doi: 10.3343/kjlm.2009.29.2.89.
3
Expansion of highly cytotoxic human natural killer cells for cancer cell therapy.
Cancer Res. 2009 May 1;69(9):4010-7. doi: 10.1158/0008-5472.CAN-08-3712. Epub 2009 Apr 21.
4
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.
J Clin Invest. 2009 May;119(5):1251-63. doi: 10.1172/JCI36022. Epub 2009 Apr 6.
6
Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells.
Blood. 2009 Jun 11;113(24):6120-7. doi: 10.1182/blood-2008-11-190421. Epub 2009 Feb 6.
7
A renaissance in understanding the multiple and diverse functions of granzymes?
Immunity. 2008 Nov 14;29(5):665-7. doi: 10.1016/j.immuni.2008.10.002.
8
HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism.
Blood. 2009 Mar 19;113(12):2851-8. doi: 10.1182/blood-2008-08-171934. Epub 2008 Nov 7.
9
Human and mouse granzyme A induce a proinflammatory cytokine response.
Immunity. 2008 Nov 14;29(5):720-33. doi: 10.1016/j.immuni.2008.08.014. Epub 2008 Oct 23.
10
Adoptive transfer of gene-modified primary NK cells can specifically inhibit tumor progression in vivo.
J Immunol. 2008 Sep 1;181(5):3449-55. doi: 10.4049/jimmunol.181.5.3449.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验